ClinicalTrials.Veeva

Menu

Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)

S

Saint Louis University (SLU)

Status

Enrolling

Conditions

Vertebral Artery Stenosis

Treatments

Other: Observational Prospective Registry

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

A retrospective and prospective registry of patients admitted for stroke and evidence of Vertebral Artery Origin Stenosis (VAOS).

Full description

A retrospective registry of stenting plus medical management for the prevention of recurrent stroke in patients with symptomatic Vertebral Artery origin Stenosis (VAOS). This study is collecting information on clinical outcomes up to 18 months post-treatment.

On January 6, 2025, VOTER was changed from prospective to retrospective.

Enrollment

150 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients between 18 and 90 years of age
  2. Patient has experienced a posterior circulation ischemic event
  3. Patient has angiographically confirmed bilateral vertebral artery origin disease (Hypoplasia, occlusion, or stenosis).
  4. Patient has >50% stenosis on the side being targeted for therapy

Exclusion criteria

  1. Pregnant women
  2. Contrast Indication to the use of anti-platelet drugs
  3. There is tandem vertebral or basilar artery stenosis
  4. The serum creatinin is >2.5
  5. Baseline modified Rankin score is >3
  6. < 5 years life expectancy

Trial contacts and locations

10

Loading...

Central trial contact

Mollie Hoffmeyer, RN, BSN; Randall Edgell, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems